cludes the orbit, eyelid, conjunctiva, uvea, retina, and optic disc [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] . With regard to ocular involvement, a lesion of the iris in cutaneous JXG that has a risk of causing spontaneous hyphema is the most frequent finding [15, 25] . The frequency of occurrence of lesions of the iris in JXG is less than that of eyelid nodules in JXG [15] . Most patients with JXG who have eyelid lesions present with a solitary lesion [19] [20] [21] [22] 28] .
We describe an unusual case of JXG with onset at 10 years of age that was located in both eyelids with multiple nodules in addition to systemic cutaneous nodules.
Case Report
A 15-year-old Japanese boy was referred to Kansai Medical University Hospital on August 5, 2013 . This patient had a painless mass on the left inner canthus that became enlarged and showed central ulceration. At the age of 10 years, this patient had systemic cutaneous nodules. At the same time, similar cutaneous nodules were confirmed at both eyelids (Fig. 1a) . This patient had already been diagnosed as cutaneous JXG by skin biopsy at the department of dermatology when he was 10 years old. Café au lait spots were not present. The patient's mother had a normal pregnancy and labor. This patient had no previous medical or ocular history. The family medical history was unremarkable for any major disorders.
An initial examination showed that the best-corrected distance visual acuity was 24/20 in each eye. Extraocular motility, eye movement, alignment, and the pupillary response were normal. The cornea, conjunctiva, and sclera showed no abnormal findings. The anterior chamber had a normal depth and was quiet. There were no nodules on the iris in each eye. Intraocular pressure and fundus examinations were normal. The size of a yellowish-brown mass at the left inner canthus was 5 × 10 mm in diameter and elastic hard with central ulceration (Fig. 1b) . The lacrimal punctum was not obstructed by the mass (Fig. 1c) . However, a local excision was required because the mass had a risk of malignancy in terms of appearance of ulceration, prevention from his visual field as right gaze, and avoiding dacryoma. The mass was totally surgically ex- cised along the left upper eyelid with sutureless technique on August 21, 2013. This operation was performed without complications. Thirty-six months after the resection, the patient had no local recurrence (Fig. 1d ). Histopathological examinations were performed for the excised mass.
The specimen of the mass was fixed in 10% buffered formaldehyde solution and processed for histopathological examinations. Two-micrometer-thick sections were prepared for microscopic examination and stained with hematoxylin and eosin (H&E). A microscopic examination of a gross section showed a partitioned structure with connective tissue and diffuse infiltration with small cells localized in the dermal layer (Fig. 2a) . Acanthosis was observed. Nodules mainly consisted of abundant foamy histiocytes and lymphocytes with partial hemorrhage (Fig. 2b) . Multinucleated giant cells were observed inside a diffuse granuloma (Fig. 2c) . A high-magnification image of a multinucleated giant cell is shown in Figure 2d . Many nuclei were arranged in a storiform pattern. The cytoplasm of giant cells showed eosinophilia, and marginal vacuolation of the cytoplasm outside the nucleus was observed. Based on these findings, we considered that these multinucleated giant cells were Touton giant cells. Touton giant cells were scattered throughout the lesion in association with moderate numbers of lymphocytes and histiocytes with a foamy cytoplasm (Fig. 2d) . There was no malignant appearance, such as nuclear atypia, an increased number of nucleoli, and anisokaryosis. The diagnosis of JXG in the eyelids was made based on the histopathological findings and clinical manifestations.
Discussion
JXG is an uncommon disorder. JXG was first described by Adamson [29] , who defined single or multiple cutaneous nodules in infancy as congenital xanthoma multiplex in 1905. JXG was named according to the appearance of cells using a microscope and was widely recognized in 1954 [30] . JXG has a bimodal distribution, under 2 years and 40 years [20] . Multiple lesions are more frequent in children aged younger than 6 months [31] . Therefore, this JXG patient was rare in terms of age of onset and multiple nodules.
JXG is mainly diagnosed by only characteristic clinical findings. Avoiding performance of histopathological examinations sometimes leads to misdiagnosis of JXG. Moreover, nodules, which are frequently observed in JXG, spontaneously regress. The pathogenesis of JXG remains unclear. The findings of macrophages and giant cells suggest that JXG is an inflammation-related and/or nonspecific injury disorder [32] . A histopathological examination is necessary to make an accurate diagnosis of JXG. The histopathology of JXG is used to diagnose the characteristic histopathological features of reactive granuloma containing foamy histiocytes, foreign body giant cells, Touton giant cells with a surrounding wreath of nuclei, histiocytes, lymphocytes, and eosinophils. We observed these findings in our patients.
JXG is classified as one form of non-Langerhans cell histiocytosis (non-LCH) histopathologically. Non-LCH consists of a variable group of disorders and comprises histiocytes that are not consistent with the criteria for diagnosis of Langerhans cells. Many disorders within non-LCH make diagnosis difficult. Non-LCH was mainly divided into 3 groups by Weitzman and Jaffe [33] (Table 1) . According to this classification, patients with JXG who only have skin lesions without systemic disorders belong to one of the "cutaneous non-LCH" disorders.
Diagnosis of JXG is suspected in patients with obvious cutaneous yellowish-orange lesions. JXG sometimes presents as a multisystem disease. Ocular involvement is one symptom of extracutaneous JXGs. Ocular involvement of JXG was first recognized in 1949 by Blank et al. [26] . Only 0.3-10% of patients with cutaneous JXG were reported to have ocular involvement [2, 14] . Therefore, ocular involvement of JXG is rare. Cutaneous JXG children under 2 years are at high risk for ocular involvement [5] . Cutaneous lesions of JXG can be confirmed before or after ocular diagnosis [2] . In our case, multiple nodules on both eyelids developed after or at the same time as cutaneous lesions when our patient was 10 years old. Within ocular involvements, eyelid involvements were found in 6-25% of patients [15, 32] . Most reports of JXG were a solitary lesion in the eyelid [19] [20] [21] [22] 28] . Because previous reports only showed a solitary lesion in the eyelid, the finding of multiple nodules in the eyelids in our patient is rare.
Dehner [3] reported that the mean age of 174 JXG patients with cutaneous lesions was 3.3 years (median, 1 year). Samara et al. [15] reported that periocular JXG appeared at a later age, at a mean age of 6.5 years (median, 2.1 years). The age of onset of JXG in our patient was 10 years. Within ocular involvement, the iris was the most common site of the lesions (68%). The conjunctiva was the second (19%) and the eyelid (6%) was the third most common site. Eyelid and conjunctiva JXGs are also rare and have a more benign course compared with JXG of the iris, which causes spontaneous hyphema with visual loss [15] .
Most reported cases of JXG were diagnosed histopathologically after surgical resection. Kuruvilla et al. [28] successfully used topical corticosteroids for treating the eyelids of a patient with JXG. In our case, a mass in the left upper eyelid was surgically resected without topical corticosteroids. Resection was performed because this mass had a risk of malignancy in terms of the appearance of ulceration and disturbance of the visual field in terms of prevention from his visual field as right gaze.
JXG is rarely linked to systemic manifestations. In particular, JXG is associated with neurofibromatosis type 1 (NF1) and juvenile chronic myelogenous leukemia (JCML) [34, 35] . JXG might be a precursor lesion of NF1. According to a report by Cambiaghi et al. [34] , one of five to six patients with NF1 had JXG during the first 3 years of life. Zvulunov et al. [35] studied triple associations among JXG, NF1, and JCML by a systematic review of the literature. They showed that children with NF1 and JXG had a 20-to 32-fold higher risk for JCML than did patients with NF1 without JXG [35] . In our case, café au lait spots of NF1 or abnormalities of blood cells were not observed. However, while our patient did not have NF1 or JCML at this time, we consider that we should screen for NF1 and JCML in the future based on these previous reports.
In summary, we describe a case of JXG that appeared on both eyelids in addition to other cutaneous lesions. Recurrence of a mass that was removed at the left inner canthus has not been observed. Systemic observations will be necessary for diseases, such as NF1 and JCML, at periodic intervals.
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